Maravai Lifesciences Holdings, Inc. SEC filings MRVI
Maravai Lifesciences Holdings, Inc. has 425 filings in SEC EDGAR's recent list, going back to Sep 8, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 12, 2025 | — |
| 424B4 | Prospectus | Sep 13, 2021 | — |
| S-1 | Registration statement | Sep 7, 2021 | — |
| 424B4 | Prospectus | Apr 9, 2021 | — |
| S-1MEF | Filing | Apr 7, 2021 | — |
| S-1/A | Amended registration statement | Apr 6, 2021 | — |
| S-1 | Registration statement | Apr 5, 2021 | — |
| S-8 | Employee stock plan registration | Nov 23, 2020 | — |
| 424B4 | Prospectus | Nov 23, 2020 | — |
| S-1MEF | Filing | Nov 19, 2020 | — |
| S-1/A | Amended registration statement | Nov 13, 2020 | — |
| S-1/A | Amended registration statement | Nov 9, 2020 | — |
| S-1 | Registration statement | Oct 29, 2020 | — |
Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MRVI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1823239
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.